search button
Open Access

Myoepithelial carcinoma of submaxillary gland: A case report

  • Authors:
    • Yuetian Li
    • Quanyi Wang

  • View Affiliations

  • Published online on: April 2, 2025     https://doi.org/10.3892/ol.2025.15007
  • Article Number: 261

  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Myoepithelial carcinoma (MEC) is a malignant tumour composed almost entirely of cells differentiated from the myoepithelium. It is rare, most commonly occurring in the parotid gland. In the current study, a rare case of MEC in the submandibular gland was presented. An 82‑year‑old male patient was admitted with a swelling in the upper left neck that had been present for 60 years. Magnetic resonance imaging indicated a tumour in the region of the left submandibular gland, which was not easy to clearly distinguish from the gland itself and an enhancement scan was recommended but not performed. Furthermore, multiple lymph nodes of varying sizes were present in the submandibular region of the neck on both sides. These enlarged lymph nodes had signs of involvement. Accordingly, a surgery was performed. The pathological diagnosis indicated the presence of a malignant tumour in the left upper neck. The tumour was most likely an MEC with pleomorphic adenoma, based on the results of immunohistochemistry. The size of the tumour mass was 5x5x4 cm. Histology indicated that the tumour cells exhibited infiltrative growth, with a sparse arrangement and a predominance of hyaline and spindle‑shaped cells. In certain regions, the tumour tissue displayed characteristics similar to pleomorphic adenoma. The results of the immunohistochemical analysis were as follows: CD31(‑), CD34(‑), cytokeratin (CK)7 (+), vimentin (+), Ki‑67 (+, 70%), erythroid growth factor receptor (‑), desmin (‑), anaplastic lymphoma kinase (‑), P40 (+), CK pan‑antibody (+) and epithelial membrane antigen (‑). The patient underwent a surgical procedure to remove the lesion in the neck under sedation with complex anaesthesia. The sample excised from the surgery was sent to the pathology department for diagnosis. Given the high recurrence frequency of MEC, monitoring patients closely after surgery is crucial. 
View Figures
View References

Related Articles

Journal Cover

June-2025
Volume 29 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Congress on Molecular Medicine Conference Banner
International Congress on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Li Y and Wang Q: Myoepithelial carcinoma of submaxillary gland: A case report. Oncol Lett 29: 261, 2025.
APA
Li, Y., & Wang, Q. (2025). Myoepithelial carcinoma of submaxillary gland: A case report. Oncology Letters, 29, 261. https://doi.org/10.3892/ol.2025.15007
MLA
Li, Y., Wang, Q."Myoepithelial carcinoma of submaxillary gland: A case report". Oncology Letters 29.6 (2025): 261.
Chicago
Li, Y., Wang, Q."Myoepithelial carcinoma of submaxillary gland: A case report". Oncology Letters 29, no. 6 (2025): 261. https://doi.org/10.3892/ol.2025.15007